openPR Logo
Press release

Global Tumor Lysis Syndrome Market 2020:Size, Industry Status and Growth opportunities for Leading Players The Menarini Group, Merck KGaA, Takeda Pharmaceutical Company Limited, Ironwood Pharmaceuticals, Inc., AstraZeneca

07-02-2020 08:05 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Tumor Lysis Syndrome Market

Global Tumor Lysis Syndrome Market

Global tumor lysis syndrome market is rising gradually with a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. The growth in this market can be attributed to factors such as development of innovative therapies.

Few of the major competitors currently working in the global tumor lysis syndrome market areSanofi, The Menarini Group, Merck KGaA, Takeda Pharmaceutical Company Limited, Ironwood Pharmaceuticals, Inc., AstraZeneca, Hikma Pharmaceuticals PLC, Pfizer Inc., Lonza, Johnson & Johnson Services, Inc., Amgen Inc, Genentech, Inc., Ionis Pharmaceuticals, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Merck & Co., Inc., Alexion Pharmaceuticals, Inc., Mallinckrodt, F. Hoffmann-La Roche Ltd, among others.

Download Sample PDF Copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-tumor-lysis-syndrome-market

Highlights of the Study

To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders
To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)
Key parameters which are driving this market and restraining its growth
What all challenges manufacturers will face as well as new opportunities and threats faced by them.
Learn about the market strategies that are being adopted by your competitors and leading organizations

Key Developments in the Market:

In October 2016, Sanofi received marketing approval from the U. S. FDA for Elitek (rasburicase), a recombinant urate oxidase enzyme used for initial management of plasma uric acid in patients that are expected to have tumor lysis syndrome (TLS) as a result of receiving different anti-cancer therapies. This approval will provide open gates for marketing of elitek, to Sanofi in the market
In June 2015, The Menarini Group received expanded indication approval in Europe for Adenuric (febuxostat), a novel drug used for treatment of patients with hyperuricemia and gout associated with intermediate to high risk of tumor lysis syndrome resulting from various chemotherapies. This indication provides adenuric (febuxostat) a clinical significance as compared to other existing drugs
Points Involved in Tumor Lysis Syndrome Market Report:

Table Of Content:

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Tumor Lysis Syndrome Market Landscape
Part 04: Global Tumor Lysis Syndrome Market Sizing
Part 05: Global Tumor Lysis Syndrome Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Get Detailed Table Of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-tumor-lysis-syndrome-market

Segmentation: Global Tumor Lysis Syndrome Market

By Pathophysiology

(Hyperuricemia, Acute Kidney Injury and Others),

Causative Therapy

(Chemotherapy, Radiation Therapy, Biological Therapy and Others),

Diagnosis

(Blood Urea Nitrogen Test, Creatinine Test, Serum Electrolytes Test and Others),

Medication

(Allopurinol, Rasburicase, Febuxostat and Others),

Route of Administration

(Oral, Injectable and Others),

End Users

(Hospitals, Homecare, Specialty Clinics, Others),

Distribution Channel

(Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others),

Geography

(North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Market Drivers

High prevalence of TLS in individuals that are introduced to initial procedures of chemotherapies is a major driver for the market growth
Development of new therapies and treatment options for tumor lysis syndrome is expected to drive the market growth
Improvement in healthcare expenditure of many developed and developing countries will also boost the market growth in the forecast period
Favorable reimbursement policies governmental support in research and development for therapies of the disease will propel the growth of global market

Market Restraints

High cost therapies are expected to hamper the market growth
Lack of awareness about the disease, its complications and treatment options in general population will hinder the market growth
Side effects related to tumor lysis syndrome therapy is another factor restricting this market growth

Inquire Regarding This Report https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tumor-lysis-syndrome-market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Tumor Lysis Syndrome Market 2020:Size, Industry Status and Growth opportunities for Leading Players The Menarini Group, Merck KGaA, Takeda Pharmaceutical Company Limited, Ironwood Pharmaceuticals, Inc., AstraZeneca here

News-ID: 2083899 • Views: 339

More Releases from Data Bridge Market Research

Global Smart Hospital Market 2021-2026 Study & Future Prospects Including key pl …
Smart Hospital Market  analysis report emphasizes on the global key manufacturers to define, illustrate and analyze the market competition landscape using SWOT analysis. To make the composition of this excellent report, a combination of best industry insight, practical solutions, talent solutions and latest technology have been employed. Furthermore, drivers and restraints of the market assessed in this market report makes aware about how the product is getting utilized in the
Nanomedicine Market 2021-Competitive Insights: Abbott, Invitae Corporation, Gene …
Nanomedicine Market research report assists directing the business in correct direction by giving insights about products, market, customers, competitors and marketing strategy at exact time. This market report endows with the productive ideas which in turn help to make the product more effective and striking in the competitive market. The report also analyses various inhibitors as well as motivators of the market in both quantitative and qualitative manners to provide
Healthcare Supply Chain Management Market to Witness High Growth in Near Future …
Healthcare Supply Chain Management Market research report assists directing the business in correct direction by giving insights about products, market, customers, competitors and marketing strategy at exact time. This market report endows with the productive ideas which in turn help to make the product more effective and striking in the competitive market. The report also analyses various inhibitors as well as motivators of the market in both quantitative and
Blockchain Technology in the Healthcare Market to Grow in Size with a Healthy CA …
Global Blockchain Technology in the Healthcare Market business document is structured with the thorough market analysis carried out by a team of industry experts, dynamic analysts, skilful forecasters and well-informed researchers. And not to mention, the report is amazingly characterized by using several charts, graphs and tables depending on the extent of data and information involved. Businesses can achieve complete knowhow of general market conditions and tendencies with the information

All 5 Releases


More Releases for Tumor

Global Tumor Ablation Market Outlook To 2026
Global Tumor Ablation Market Outlook To 2026: In-Depth Market Overview, Key Treatment Type (Surgical, Percutaneous), Technology (Cryoablation, IRE, MWA, RFA), Application Categories (Liver, Lung, Breast, Prostate), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion The Tumor Ablation Market was valued at $1.08Billion in 2018 and is forecast to grow at a modest12.2% CAGR between2018 and 2025, culminating in 2026 global sales of $4.2Billion. Tumor Ablation
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for